Login Contact Us
Oct 2023, Vol 11, Issue 4
Advanced Search
Title
Authors
Keyword
Poll
How do you find the scientific quality of the published articles on our web site?


Case Series
Cesarean Scar Pregnancy: A Tertiary Care Center Experience
Sarah M Ghazali
Department of Obstetrics and Gynecology, King Abdulaziz University, Jeddah, Saudi Arabia

IJWHR 2023; 11: 191-196
DOI: 10.15296/ijwhr.2023.8052
Viewed : 1124 times
Downloaded : 921 times.

Keywords : Scar ectopic, cesarean, Methotrexate, Case series, Intra-gestational injection
Full Text(PDF) | Related Articles
Abstract
Objectives: To describe the management and treatment outcomes of cesarean scar pregnancies diagnosed in a tertiary care center.

Methods: This study retrospectively described all cases of cesarean scar pregnancy diagnosed and managed at a tertiary care center over a 3-year period. Maternal demographics, clinical presentation, treatment methods, and outcomes were all included in the analysis.

Results: uring the study period, 5 cases of cesarean scar pregnancy were diagnosed and managed. The median gestational age at diagnosis was 8 weeks, and all fetuses had positive cardiac activity. All cases were initially treated with systemic intramuscular (IM) methotrexate (MTX), but only one case responded well due to fetal bradycardia present prior to treatment. One patient received further management with transvaginal intracardiac potassium chloride (KCL) injection, which resulted in maternal sepsis, hemorrhage, and ICU admission. The other 3 cases were managed by transabdominal intra-gestational sac MTX +/- KCL and showed good clinical response. Two of these cases required an interval dilation & curettage (D&C) due to persistent vaginal spotting with no complications.

Conclusions: It is recommended to avoid using systemic IM MTX as the first-line treatment for scar pregnancy unless the pregnancy is failing or non-viable. Intra-gestational sac treatment may cause persistent retained products of conception, leading to bothersome vaginal spotting. An interval ultrasound guided D&C appears to be safe for managing this complication, but the exact interval needs to be determined through further studies. Sepsis is a rare complication of invasive medical treatment, and close surveillance is advised.

Cite By, Google Scholar

Google Scholar

Articles by M Ghazali S

PubMed

Articles by Sarah M Ghazali

Submit Paper
Online Submission System
IJWHR ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Published Article Statistics